UAE
Bahrain
Jordan
Kuwait
Oman
Qatar
Saudi ArabiaHealth News
Virginia Tech researchers work with new wireless technologies to improve hospitals
Date: Feb-27-2014Medical mistakes happen every day, even with the best doctors and nurses. One way to reduce medical errors is to adopt new wireless technologies that improve health care and reduce costs, according to researchers with Virginia Tech's Institute for Critical Technology and Applied Science.Hospitals are dense electromagnetic environments with multiple wireless devices working in one room. The problem is these devices do not work well together and often interfere with each other.
Glycerol Phenylbutyrate reduces hepatic encephalopathy events and ammonia levels compared to placebo in a Phase 2 trial
Date: Feb-27-2014Phase 2 trial results published in Hepatology, a journal of the American Association for the Study of Liver Diseases, suggests the potential for Glycerol Phenylbutyrate (GPB) to reduce hepatic encephalopathy episodes in patients with cirrhosis, with a safety profile similar to placebo.Patients with hepatic encephalopathy experience neuropsychiatric symptoms that may range from mild confusion to coma. There is conflicting evidence on the link between elevated blood ammonia and hepatic encephalopathy.
Biosense Webster gets FDA approval of THERMOCOOL® SMARTTOUCH® Ablation Catheter
Date: Feb-27-2014Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, has announced that it has received approval from the United States Food and Drug Administration (FDA) for its THERMOCOOL® SMARTTOUCH® Catheter. This device is the first therapeutic catheter approved in the U.S. that enables direct and real-time measurement of contact force during catheter ablation procedures for patients suffering from drug-resistant paroxysmal atrial fibrillation (Afib), sustained monomorphic ischemic ventricular tachycardia and Type I atrial flutter.
Glycerol Phenylbutyrate reduces hepatic encephalopathy events and ammonia levels compared to placebo in a Phase 2 trial
Date: Feb-27-2014Phase 2 trial results published in Hepatology, a journal of the American Association for the Study of Liver Diseases, suggests the potential for Glycerol Phenylbutyrate (GPB) to reduce hepatic encephalopathy episodes in patients with cirrhosis, with a safety profile similar to placebo.Patients with hepatic encephalopathy experience neuropsychiatric symptoms that may range from mild confusion to coma. There is conflicting evidence on the link between elevated blood ammonia and hepatic encephalopathy.
Leading gastroenterology practices announce formation of digestive health physicians association
Date: Feb-27-2014Eleven of the country's leading gastroenterology (GI) practices have announced the formation of the Digestive Health Physicians Association (DHPA), a trade association comprised of independent gastroenterology physician practices with the aim of promoting and preserving the integrated model of healthcare delivery.
Leading gastroenterology practices announce formation of digestive health physicians association
Date: Feb-27-2014Eleven of the country's leading gastroenterology (GI) practices have announced the formation of the Digestive Health Physicians Association (DHPA), a trade association comprised of independent gastroenterology physician practices with the aim of promoting and preserving the integrated model of healthcare delivery.
Fewer low risk urine test results may reduce unnecessary antibiotic treatment
Date: Feb-27-2014A simple change in how the hospital laboratory reports test results may help improve antibiotic prescribing practices and patient safety, according to a pilot, proof-of-concept study published in Clinical Infectious Diseases and now available online. No longer routinely reporting positive urine culture results for inpatients at low risk for urinary tract infections (UTIs) greatly reduced unnecessary antibiotic prescriptions and did not affect the treatment of patients who did need antibiotics, the study authors found.Urine cultures for hospitalized patients are often ordered unnecessarily.
Fewer low risk urine test results may reduce unnecessary antibiotic treatment
Date: Feb-27-2014A simple change in how the hospital laboratory reports test results may help improve antibiotic prescribing practices and patient safety, according to a pilot, proof-of-concept study published in Clinical Infectious Diseases and now available online. No longer routinely reporting positive urine culture results for inpatients at low risk for urinary tract infections (UTIs) greatly reduced unnecessary antibiotic prescriptions and did not affect the treatment of patients who did need antibiotics, the study authors found.Urine cultures for hospitalized patients are often ordered unnecessarily.
MIND Institute launches 'Colombia Project of Hope' to investigate fragile X-related disorders
Date: Feb-27-2014Researchers at the internationally respected UC Davis MIND Institute are collaborating with scientists at two Colombian universities to investigate the very high rate of fragile X-related disorders in one region in the South American country. Named the "Colombia Project of Hope," the initiative aims to advance fragile X research and benefit individuals with fragile X-related disorders in the United States and around the world by focusing on a recently identified fragile X "hotspot" in Colombia.
Female Genital Mutilation is child abuse and should be dealt with as a safeguarding issue, say UK GPs
Date: Feb-27-2014GPs who suspect that a child has been subjected to Female Genital Mutilation should refer the parent or guardian to social services, says the Royal College of General Practitioners. In its written evidence to the Home Office Select Committee released today, the RCGP describes FGM as 'child abuse' and calls for it to be treated as a safeguarding issue. However, the College also raises concerns about the capacity of social services to respond to referrals and is calling for a multi-agency approach to better support the young girls and women affected.
Stay Connected
